Myeloid cell iron uptake pathways and paramagnetic rim formation in multiple sclerosis.

CD163 Haptoglobin Iron metabolism Magnetic resonance imaging Multiple sclerosis Postmortem White matter

Journal

Acta neuropathologica
ISSN: 1432-0533
Titre abrégé: Acta Neuropathol
Pays: Germany
ID NLM: 0412041

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 28 04 2023
accepted: 23 08 2023
revised: 01 08 2023
pubmed: 16 9 2023
medline: 16 9 2023
entrez: 16 9 2023
Statut: ppublish

Résumé

In multiple sclerosis (MS), sustained inflammatory activity can be visualized by iron-sensitive magnetic resonance imaging (MRI) at the edges of chronic lesions. These paramagnetic rim lesions (PRLs) are associated with clinical worsening, although the cell type-specific and molecular pathways of iron uptake and metabolism are not well known. We studied two postmortem cohorts: an exploratory formalin-fixed paraffin-embedded (FFPE) tissue cohort of 18 controls and 24 MS cases and a confirmatory snap-frozen cohort of 6 controls and 14 MS cases. Besides myelin and non-heme iron imaging, the haptoglobin-hemoglobin scavenger receptor CD163, the iron-metabolizing markers HMOX1 and HAMP as well as immune-related markers P2RY12, CD68, C1QA and IL10 were visualized in myeloid cell (MC) subtypes at RNA and protein levels across different MS lesion areas. In addition, we studied PRLs in vivo in a cohort of 98 people with MS (pwMS) via iron-sensitive 3 T MRI and haptoglobin genotyping by PCR. CSF samples were available from 38 pwMS for soluble CD163 (sCD163) protein level measurements by ELISA. In postmortem tissues, we observed that iron uptake was linked to rim-associated C1QA-expressing MC subtypes, characterized by upregulation of CD163, HMOX1, HAMP and, conversely, downregulation of P2RY12. We found that pwMS with [Formula: see text] 4 PRLs had higher sCD163 levels in the CSF than pwMS with [Formula: see text] 3 PRLs with sCD163 correlating with the number of PRLs. The number of PRLs was associated with clinical worsening but not with age, sex or haptoglobin genotype of pwMS. However, pwMS with Hp2-1/Hp2-2 haplotypes had higher clinical disability scores than pwMS with Hp1-1. In summary, we observed upregulation of the CD163-HMOX1-HAMP axis in MC subtypes at chronic active lesion rims, suggesting haptoglobin-bound hemoglobin but not transferrin-bound iron as a critical source for MC-associated iron uptake in MS. The correlation of CSF-associated sCD163 with PRL counts in MS highlights the relevance of CD163-mediated iron uptake via haptoglobin-bound hemoglobin. Also, while Hp haplotypes had no noticeable influence on PRL counts, pwMS carriers of a Hp2 allele might have a higher risk to experience clinical worsening.

Identifiants

pubmed: 37715818
doi: 10.1007/s00401-023-02627-4
pii: 10.1007/s00401-023-02627-4
pmc: PMC10564819
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

707-724

Subventions

Organisme : International Progressive MS Alliance
ID : PA-2002-36405

Informations de copyright

© 2023. The Author(s).

Références

Ann Clin Transl Neurol. 2021 Apr;8(4):877-886
pubmed: 33704933
J Biol Chem. 2004 Dec 3;279(49):51561-7
pubmed: 15448162
Arch Neurol. 2010 Jul;67(7):812-8
pubmed: 20625086
Nature. 1956 Sep 29;178(4535):694-5
pubmed: 13369501
Annu Rev Immunol. 2001;19:683-765
pubmed: 11244051
J Neuropathol Exp Neurol. 2015 Jan;74(1):48-63
pubmed: 25470347
Clin Chem. 2002 Sep;48(9):1377-82
pubmed: 12194911
J Neuroinflammation. 2013 Mar 04;10:35
pubmed: 23452918
PLoS One. 2013;8(3):e57573
pubmed: 23516409
Annu Rev Nutr. 2022 Aug 22;42:311-335
pubmed: 35508203
J Clin Invest. 2016 Jul 1;126(7):2597-609
pubmed: 27270171
Int J Lab Hematol. 2007 Apr;29(2):92-110
pubmed: 17474882
Arch Histol Cytol. 2007 Apr;70(1):1-19
pubmed: 17558140
Trends Immunol. 2021 Mar;42(3):228-247
pubmed: 33593693
Neurology. 2009 Dec 1;73(22):1914-22
pubmed: 19949037
Brain. 2013 Jun;136(Pt 6):1799-815
pubmed: 23687122
Clin Chim Acta. 1997 Feb 17;258(2):137-44
pubmed: 9074811
J Exp Med. 1991 Dec 1;174(6):1549-55
pubmed: 1744584
Front Neurol. 2022 Jun 29;13:928582
pubmed: 35865643
Front Neurol. 2021 Dec 21;12:632749
pubmed: 34992573
Nature. 2017 Jan 26;541(7638):481-487
pubmed: 28099414
J Am Heart Assoc. 2014 May 16;3(3):e000732
pubmed: 24837587
J Clin Invest. 2011 Mar;121(3):985-97
pubmed: 21317534
Neurology. 2021 Aug 10;97(6):e543-e553
pubmed: 34088875
Int J Mol Sci. 2021 Jun 17;22(12):
pubmed: 34204327
Neuroimage Clin. 2014 Nov 08;7:7-17
pubmed: 25429357
Acta Neuropathol. 2017 Jan;133(1):25-42
pubmed: 27796537
Ann Neurol. 2022 Sep;92(3):486-502
pubmed: 35713309
Brain Pathol. 2018 Nov;28(6):791-805
pubmed: 29222823
J Biol Chem. 2018 May 18;293(20):7853-7863
pubmed: 29610275
Ann Clin Transl Neurol. 2019 Nov;6(11):2150-2163
pubmed: 31675181
Acta Neuropathol. 2015 Aug;130(2):263-77
pubmed: 26087903
Brain. 2009 May;132(Pt 5):1175-89
pubmed: 19339255
Mult Scler Relat Disord. 2022 Jan;57:103340
pubmed: 35158450
Nature. 2021 Sep;597(7878):709-714
pubmed: 34497421
Nat Neurosci. 2023 Mar;26(3):406-415
pubmed: 36747024
J Biol Chem. 2014 Jan 10;289(2):778-88
pubmed: 24275664
J Neuroimmunol. 2011 Aug 15;237(1-2):73-9
pubmed: 21737148
J Mol Neurosci. 2007;32(1):25-37
pubmed: 17873285
Nat Rev Neurol. 2023 May;19(5):289-304
pubmed: 37055617
Brain. 2017 Jul 1;140(7):1900-1913
pubmed: 28541408
Wellcome Open Res. 2016 Nov 15;1:10
pubmed: 27996064
Ann Neurol. 2013 Dec;74(6):848-61
pubmed: 23868451
Acta Neuropathol. 2022 Nov;144(5):987-1003
pubmed: 36112223
Cells. 2020 May 09;9(5):
pubmed: 32397365
Biomolecules. 2021 Apr 16;11(4):
pubmed: 33923744
Mult Scler. 2023 Mar;29(3):374-384
pubmed: 36537667
Neuron. 2017 Dec 6;96(5):1003-1012.e7
pubmed: 29103804
Ann Neurol. 2007 Jul;62(1):67-80
pubmed: 17503512
Ann Neurol. 2013 Nov;74(5):669-78
pubmed: 23813441
Am J Pathol. 2000 Jul;157(1):267-76
pubmed: 10880396
J Neuropathol Exp Neurol. 2006 Sep;65(9):855-65
pubmed: 16957579
Nature. 2019 Sep;573(7772):75-82
pubmed: 31316211
Glia. 2017 Feb;65(2):375-387
pubmed: 27862351
Free Radic Biol Med. 2004 Dec 15;37(12):1995-2011
pubmed: 15544918
Eur Radiol. 2022 Mar;32(3):2012-2022
pubmed: 34549326
Mult Scler J Exp Transl Clin. 2019 Nov 04;5(4):2055217319885984
pubmed: 31723437
Acta Neuropathol. 2017 Jul;134(1):45-64
pubmed: 28332093
Am J Pathol. 2008 Mar;172(3):725-37
pubmed: 18276779
Brain. 2021 Apr 12;144(3):833-847
pubmed: 33484118
JAMA Neurol. 2019 Dec 1;76(12):1474-1483
pubmed: 31403674
Brain. 2011 Dec;134(Pt 12):3602-15
pubmed: 22171355
J Neuroimaging. 2023 Mar;33(2):240-246
pubmed: 36504270
Brain. 2019 Jul 1;142(7):1858-1875
pubmed: 31209474
Stroke. 2022 May;53(5):1633-1642
pubmed: 35196874

Auteurs

Annika Hofmann (A)

Department of Neurology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Nik Krajnc (N)

Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria.
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Department of Neurology, Medical University of Vienna, Vienna, Austria.

Assunta Dal-Bianco (A)

Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria.
Department of Neurology, Medical University of Vienna, Vienna, Austria.

Christian J Riedl (CJ)

Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria.
Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria.

Tobias Zrzavy (T)

Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria.
Department of Neurology, Medical University of Vienna, Vienna, Austria.

Celia Lerma-Martin (C)

Department of Neurology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Gregor Kasprian (G)

Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria.
Division of Neuroradiology and Musculoskeletal Radiology, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.

Claudia E Weber (CE)

Department of Neurology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Francesco Pezzini (F)

Department of Surgery, Dentistry, Paediatrics and Gynaecology, University of Verona, Verona, Italy.
Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.

Fritz Leutmezer (F)

Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria.
Department of Neurology, Medical University of Vienna, Vienna, Austria.

Paulus Rommer (P)

Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria.
Department of Neurology, Medical University of Vienna, Vienna, Austria.

Gabriel Bsteh (G)

Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria.
Department of Neurology, Medical University of Vienna, Vienna, Austria.

Michael Platten (M)

Department of Neurology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Mannheim Center for Translational Neuroscience, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Mannheim Institute for Innate Immunity, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Interdisciplinary Center for Neurosciences, Heidelberg University, Heidelberg, Germany.
DKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center, INF 280, Heidelberg, Germany.

Achim Gass (A)

Department of Neurology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Mannheim Center for Translational Neuroscience, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Thomas Berger (T)

Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria.
Department of Neurology, Medical University of Vienna, Vienna, Austria.

Philipp Eisele (P)

Department of Neurology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Mannheim Center for Translational Neuroscience, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Roberta Magliozzi (R)

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.

Lucas Schirmer (L)

Department of Neurology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. lucas.schirmer@medma.uni-heidelberg.de.
Mannheim Center for Translational Neuroscience, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. lucas.schirmer@medma.uni-heidelberg.de.
Mannheim Institute for Innate Immunity, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. lucas.schirmer@medma.uni-heidelberg.de.
Interdisciplinary Center for Neurosciences, Heidelberg University, Heidelberg, Germany. lucas.schirmer@medma.uni-heidelberg.de.

Simon Hametner (S)

Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria. simon.hametner@meduniwien.ac.at.
Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria. simon.hametner@meduniwien.ac.at.

Classifications MeSH